Leveraging ΔFosB as a potential therapeutic for Alzheimer's Disease

Medicine & Life Sciences

1. Substance-Related Disorders 100%
2. Oxidation-Reduction 70%
3. Cognitive Dysfunction 60%
4. Organized Financing 43%
5. Pharmaceutical Preparations 37%
6. Alzheimer Disease 35%
7. Nucleus Accumbens 33%
8. Cocaine 31%
9. N-nitrosoiminodiacetic acid 31%
10. Hippocampus 29%
11. Translational Medical Research 29%
12. Learning 26%
13. Memory 26%
14. Gene Expression 25%
15. Pharmaceutical Chemistry 25%
16. Brain 24%
17. Transcription Factors 23%
18. Biomarkers 23%
19. Animal Models 23%
20. DNA 22%
21. Dimerization 20%
22. Therapeutics 20%
23. Addictive Behavior 19%
24. Preliminary Data 19%
25. Drive 18%
26. Mutagenesis 18%
27. Cyclin-Dependent Kinase 5 17%
28. Genes 15%
29. Cognition 14%
30. Reward 14%
31. Drug-Seeking Behavior 9%
32. Self Administration 8%
33. Heroin 8%
34. Drug Discovery 7%
35. AMPA Receptors 7%
36. Proteins 6%
37. Glutamate Receptors 6%
38. Lead 6%
39. Opioid Analgesics 6%
40. Rodentia 6%
41. In Vitro Techniques 5%
42. Public Health 5%